Marshall Wace’s Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares FLAC Stock Holding History

Marshall Wace’s Portfolio FLAC Stock Details FLAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-151,878	Closed	-$1.51M	–	3827
2022 Q3	$1.51M	Hold	151,878	–	–	﹤0.01%	2189
2022 Q2	$1.5M	Hold	151,878	–	–	﹤0.01%	2192
2022 Q1	$1.49M	Buy	151,878 +590	+0.4%	+$5.78K	﹤0.01%	2239
2021 Q4	$1.48M	Buy	+151,288	New	+$1.48M	﹤0.01%	2241

Marshall Wace's FLAC Position: Q4 2022 in Review

Marshall Wace sold out of Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares (FLAC) in Q4 2022, closing a stake of 151,878 shares — an estimated $1.51M sold.

Marshall Wace first reported a position in FLAC in Q4 2021 and held it in 4 quarters. The position peaked at $1.51M in Q3 2022. 0 funds tracked by Wall St. Rank hold FLAC as of Q4 2022.

Marshall Wace reported no remaining Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares position as of Q4 2022 after selling out during the quarter.
Marshall Wace sold 151,878 Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares shares in Q4 2022, an estimated $1.51M.
Marshall Wace first reported a position in Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares in Q4 2021 and held it in 4 quarters.
Marshall Wace's Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares position peaked at $1.51M in Q3 2022.
0 funds tracked by Wall St. Rank held Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares as of Q4 2022.

Based on Marshall Wace's 13F filing for Q4 2022, filed 14 Feb 2023.